Our commitment to innovation has become one of the company's main assets today. Innovation has allowed us to forge vital partnerships with cutting-edge biotechnology firms and major universities. Thanks to innovation, we have been able to maintain our competitive edge in an increasingly competitive environment. Our performance and our know-how have made us a world leader in the vaccine industry. Our success serves to illustrate the growing importance of vaccines for advancing health. 

In Australia and New Zealand, we have vaccines against bacterial and viral diseases, such as Cholera, Diphtheria, Haemophilus influenzae  type b Infections, Meningococcal Infections, Pertussis, Tetanus, Tuberculosis, Typhoid Fever, Hepatitis A, Influenza, Japanese Encephalitis, Poliomyelitis, Rabies, Yellow Fever.

To find out more about our vaccines division, click here to access the sanofi pasteur Australian website